View Marvelon overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food: Take at the same time each day.
Contraindications
Hypersensitivity. Presence or history of venous & arterial thrombosis or prodromal conditions (eg, transient ischaemic attack, angina pectoris). Known predisposition & presence of severe or multiple risk factors for venous or arterial thrombosis. History of migraine w/ focal neurological symptoms. DM w/ vascular involvement. Pancreatitis or history associated w/ severe hypertriglyceridaemia. Known or suspected sex steroid-influence malignancies; undiagnosed vag bleeding. Major surgery w/ prolonged immobilisation. Concomitant use w/ HCV combination drug regimen. Severe hepatic disease, benign or malignant liver tumours. Known or suspected pregnancy.
Increased risk of arterial & venous thrombotic & thromboembolic diseases; increasing age, +ve family history of venous or arterial thromboembolism, obesity, prolonged immobilisation, major surgery & trauma, leg surgery, superficial thrombophlebitis, varicose veins, smoking, dyslipoproteinaemia, HTN, migraine, valvular heart disease, atrial fibrillation; DM; SLE; haemolytic uraemic syndrome; Crohn's disease or ulcerative colitis; sickle cell disease. Hypertriglyceridaemia; gallstone formation; porphyria; Sydenham's chorea; herpes gestationis; otosclerosis-related hearing loss; hereditary angioedema. Chloasma; GI disturbances. Concomitant use w/ HCV combination drugs. Galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Exclude malignancy prior to therapy; irregular bleeding (eg, spotting or breakthrough bleeding) during 1st mth of use. Benign or malignant liver tumours; jaundice &/or pruritus related to cholestasis. Not to be used during pregnancy. Not recommended during lactation.
G03AA09 - desogestrel and ethinylestradiol ; Belongs to the class of progestogens and estrogens in fixed combinations. Used as systemic contraceptives.
Sign Out
